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Herein  we  report  the  use of  immunostimulant-loaded  nanoliposomes  (called  NLc liposomes)  as  a  strategy
to  protect  ﬁsh against  bacterial  and/or  viral  infections.  This  work  entailed  developing  a method  for  in  vivo
tracking of  the  liposomes  administered  to  adult  zebraﬁsh  that  enables  evaluation  of their  in  vivo  dynam-
ics  and  characterisation  of  their  tissue  distribution.  The  NLc liposomes,  which  co-encapsulate  poly(I:C)
and  LPS,  accumulate  in immune  tissues  and  in  immunologically  relevant  cells  such  as  macrophages,  as
has been  assessed  in  trout  primary  cell  cultures.  They  protect  zebraﬁsh  against  otherwise  lethal  bacterial
(Pseudomonas  aeruginosa  PAO1) and  viral  (Spring  Viraemia  of Carp  Virus)  infections  regardless  of  whetheriposome
mmunostimulant
nnate immunity
acrophage
ebraﬁsh
nfection model
they  are  administered  by injection  or  by immersion,  as  demonstrated  in  a  series  of  in  vivo infection  exper-
iments  with adult  zebraﬁsh.  Importantly,  protection  was  not  achieved  in  ﬁsh  that had  been  treated  with
empty  liposomes  or with  a  mixture  of  the  free  immunostimulants.  Our  ﬁndings  indicate  that  stimulation
of  the innate  immune  system  with  co-encapsulated  immunostimulants  in nano-liposomes  is  a promising
strategy  to simultaneously  improve  the  levels  of  protection  against  bacterial  and viral  infections  in  ﬁsh.
© 2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
The immune system of vertebrates encompasses adaptive
mmunity and innate immunity, the former of which involves
mmunological memory. Fish posses a highly diverse, strong innate
mmune system and were the ﬁrst vertebrates to develop an
daptive immune system. Interestingly, ﬁsh lack IgG and class
witch-recombination machinery [1], but have IgM, IgT and IgD
enerated by somatic rearrangement, somatic mutation and gene
onversion [2]. Another important distinctive feature of teleosts
s that they have phagocytic B lymphocytes. It has been reported
he presence of phagocytic B lymphocytes in trout, catﬁsh, cod and
∗ Corresponding author at: Institut de Biotecnologia i Biomedicina (IBB), Univer-
itat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
el.: +34 93 581 2805; fax: +34 93 581 2011.
E-mail address: nerea.roher@uab.cat (N. Roher).
ttp://dx.doi.org/10.1016/j.vaccine.2014.05.010
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Atlantic salmon ([1] and references herein) but not in zebraﬁsh
[3]. Nevertheless, farm-raised ﬁsh respond well to vaccination.
Recently, the concept of “innate memory” has been proposed [4,5]
and has also inspired the design of vaccination approaches focused
on the stimulation of innate immunity.
Several ﬁsh vaccines against viral or bacterial diseases, most
of which comprise inactivated pathogens are now available [6].
However, researchers are working intensively to enhance vaccine
efﬁciency by developing new vaccines, containing adjuvants and
immunostimulants [7], and new formulations based on encapsu-
lation [8–12]. Encapsulating vaccines makes them more stable to
the environment and to low pH and/or enzymatic reactions inside
the treated organism [12,13]. Among the various encapsulation
systems available, liposomes are especially attractive, as they are
biocompatible and highly tuneable [14]; can actually enhance the
efﬁcacy of the vaccine, as has been reported in ﬁsh [15,16]; and can
be used as labels to enable in vitro or in vivo tracking of the vaccine.
Another factor that researchers are endeavouring to improve in
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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sh vaccines is administration, which is typically done by injection
n adults. Research efforts are focused on creating non-stressful,
asy to manage and low-cost vaccination protocols to improve
arge-scale procedures based on immersion rather than on injection
6,17].
Our group recently developed nanoliposomes (called NLc
iposomes)  for simultaneous wide-spectrum anti-bacterial and
nti-viral protection of farm-raised ﬁsh. First, we co-encapsulate
wo general immunostimulants: bacterial lipopolysaccharide (LPS)
nd poly(I:C), a synthetic analogue of dsRNA viruses. Then, we
emonstrated that the NLc liposomes were taken up in vitro by
acrophages and that they regulated the expression of immuno-
ogically relevant genes (likely, by triggering innate immune
ignalling pathways) [18].
In the work reported here, we studied the biodistribution and
mmunological efﬁcacy of NLc liposomes in zebraﬁsh in vivo. We
hose zebraﬁsh as the model organism for the in vivo assays
or multiple reasons: they have been widely used to study the
athogenicity of different ﬁsh and human pathogens; they have
nnate and adaptive immune systems; and they are easy to breed
nd handle [19]. We  adapted a non-invasive imaging method
idely used in mammalian models [20,21], and then used it to
rack the nanoliposomes in adult zebraﬁsh in vivo. To the best of
ur knowledge, this is the ﬁrst report of this method being applied
o live zebraﬁsh. In addition, we studied which cells were preferen-
ially targeted by the NLc liposomes in rainbow trout (Oncorhynchus
ykiss), by performing ex vivo analysis of the main immune rele-
ant tissues. We  also developed a new model for infection of adult
ebraﬁsh by the bacterium Pseudomonas aeruginosa, an opportunis-
ic pathogen in ﬁsh and in humans [22,23]. Although most of the
ebraﬁsh infection models employ larvae [24], the maturity of lar-
al immune systems remains poorly understood. We  believe that
he development of infection models in adult zebraﬁsh might ulti-
ately prove valuable for designing new therapeutic approaches
nd for elucidating the functions of the teleost immune system.
. Materials and methods
.1. Preparation and lyophilisation of NLc liposomes
The NLc (NanoLiposome cocktail) liposomes were prepared as
reviously described in Ruyra et al. [18]. Liposomal formulations
ere prepared by the thin ﬁlm hydratation method [25] with some
odiﬁcations. Brieﬂy, DOPA, DLPC, cholesterol, cholesteryl and
hol-PEG600 were dissolved in chloroform solutions (100 mg/ml)
nd mixed at the desired molar ratios (0.5:0.35:0.10:0.05). The
rganic solvent was then evaporated by rotary evaporation to
btain a dry lipid ﬁlm. For the preparation of the liposomes
hat contained a cocktail of immunostimulants the dry lipid ﬁlm
as hydrated with a solution containing 0.5 mg/ml poly(I:C) and
.0 mg/ml  LPS in PBS. The co-encapsulation of poly(I:C) and LPS was
one with an immunostimulant:lipid ratio of 1:30 and 1:15, respec-
ively. The resulting lipid suspensions were then vigorously shaken
nd were homogenised by means of an extruder (Lipex Biomem-
ranes, Canada) through 2 stacked polycarbonate membranes
200 nm pore size, Avanti Polar Lipids) to ﬁnally obtain unilamel-
ar liposomes. In all cases, non-encapsulated immunostimulants
ere removed from liposome preparations by ultracentrifuga-
ion at 110,000 × g for 30 min  at 10 ◦C. Liposome integrity was
hecked by DLS and Cryo-TEM. The ﬁnal NLc liposomes com-
rised 125.8 ± 6.6 nm liposomes containing both poly(I:C) and
PS (1 mg/ml  liposome encapsulates 33.3 g/ml poly(I:C) and
6.6 g/ml LPS) and had a neutral surface charge (1.37 ± 3.58 mV).
he co-encapsulation efﬁciencies (EE) were of 22.3 ± 2.1% for LPS
nd of 99.6 ± 0.1% for poly(I:C). For long-term conservation, the (2014) 3955–3962
cryoprotectant trehalose was  incorporated into the procedure.
The dry lipid ﬁlm was  hydrated with a solution containing the
immunostimulants and trehalose at a lipid/carbohydrate ratio of
1:5 (2.7%, w/v). The resulting NLc liposomes were frozen in liq-
uid nitrogen, lyophilised (48 h at −80 ◦C) and ﬁnally, stored at RT
for several weeks. When needed, the lyophilised samples were re-
suspended in PBS and the morphology of the reconstituted NLc
liposomes was  assessed by Cryo-TEM (JEOL-JEM 1400, Japan). To
quantify the amount of immunostimulants leaked after lyophilisa-
tion, liposomes encapsulating either poly(I:C) or LPS were prepared
lyophilised and ﬁnally, stored at RT. At 0 h and 4 months, the dried
liposomal cakes were resuspended with PBS and the free poly(I:C)
or LPS was separately quantiﬁed as described in Ruyra et al. [18].
2.2. Animals
Adult wild type (wt) zebraﬁsh were held in tanks with recircu-
lating water under 14 h light/10 h dark at 28 ◦C. Adult rainbow trout
(O. mykiss) were held in tanks under 12 h light/12 h dark at 15 ◦C.
All the experimental protocols with animals were reviewed and
approved by the Ethics and Animal Welfare Committee and Biose-
curity Committee of the Universitat Autònoma de Barcelona and
Universidad Miguel Hernandez. All of these protocols followed the
International Guiding Principles for Research Involving Animals.
2.3. Fluorescent labelling of NLc liposomes
Alexa Fluor 750 (AF750) succinimidyl ester and DOPE-NH2
were conjugated as previously described [25]. Only conjugated
Alexa Fluor 750 was  detected by TLC (Rf = 0.6), indicating that
conjugation was complete. The ﬂuorescently labelled AF750-NLc
liposomes were prepared by incorporating AF750-DOPE into the
lipid mixture (0.01 molar ratio). Similarly, ﬂuorescently labelled
FITC-NLc liposomes were prepared by incorporating Fluorescein-
DHPE (Molecular Probes, Life Technologies Corp., USA) into the lipid
mixture (0.01 molar ratio).
2.4. Biodistribution of the NLc liposomes in zebraﬁsh
The in vivo biodistribution of the NLc liposomes in adult
zebraﬁsh (0.39 ± 0.04 g weight) was  studied using the AF750-NLc
liposomes. The liposomes were administered by intraperitoneal
(i.p.) injection or by immersion. Administration by i.p. injection:
adult zebraﬁsh (n = 4 per condition) were anaesthetised (MS-222,
40 ppm) and given 10 l of AF750-NLc liposomes (380 mg/kg lipo-
some containing 12.6 mg/kg of poly[I:C] and 6.3 mg/kg of LPS).
At 24, 48 and 72 h post-injection, the ﬁsh were anaesthetised
(160 ppm) and imaged in the IVIS Spectrum platform (excita-
tion: 745 nm; emission: 800/820/840 nm,  Calliper, PerkinElmer,
USA). For the ex vivo imaging, the zebraﬁsh were killed by over-
anaesthetisation (200 ppm) and their organs were extracted and
then, imaged in the IVIS Spectrum platform. Administration by
immersion: adult zebraﬁsh (n = 4 per condition) were immersed in
a tank containing AF750-NLc liposomes (500 g/ml liposome con-
taining 16.6 g/ml of poly(I:C) and 8.3 g/ml of LPS) for 30 min,
and then placed back into a tank of clean water. At 0 and 12 h
post-immersion, the ﬁsh were anaesthetised and imaged in the
IVIS Spectrum platform (as described above). For the ex vivo imag-
ing analyses, the zebraﬁsh were killed by over-anaesthetisation
(200 ppm), and their organs were extracted and then, imaged in the
IVIS Spectrum platform. The images were analysed using Caliper
Living Image 4.1 software (PerkinElmer). For the ex vivo analysis,
the Region of Interest (ROI) was  measured and the data were rep-
resented as the Radiance Efﬁciency (RE) divided by the mean area
of each organ.
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.5. Targeting of cells by the NLc liposomes in rainbow trout
FITC-NLc liposomes were used to study the cells targeted by
he NLc liposomes in rainbow trout. Animals (n = 4, ∼125 g weight)
ere anaesthetised and i.p. injected with 200 l of FITC-NLc lipo-
omes (96.0 mg/kg liposome containing 3.18 mg/kg of poly(I:C)
nd 1.59 mg/kg of LPS) or 200 l PBS (controls). After 24 h, the
sh were sacriﬁced for head kidney and spleen dissection. Adher-
nt trout monocyte/macrophages were isolated as previously
escribed [26]. Every 24 h, cells were studied by ﬂow cytometry
nalysis (FACSCanto cytometer, Becton Dickinson, USA) or by con-
ocal microscopy imaging (Zeiss LSM 700, Germany).
.6. P. aeruginosa bacterial challenge in zebraﬁsh after NLc
iposome administration
Adult zebraﬁsh (0.61 ± 0.12 g weight) were transferred to an iso-
ated system and acclimated for 1 day before each experiment. P.
eruginosa (PAO1, sub-line MPAO1; obtained from Seattle PAO1
ransposon mutant library, University of Washington) was  grown
t 37 ◦C in blood agar plates (BioMérieux, France), collected directly
rom the plates and then, dispersed in sterile PBS. The LD50 for
AO1 infection was calculated in ﬁsh infected by i.p. injection
ith 20 l of PAO1 suspension at concentrations ranging from
.2 × 107 to 2.5 × 108 cfu. The ﬁsh were observed daily for signs
f disease and mortality, and the dead ﬁsh were assessed for
acterial presence and identiﬁcation (data not shown). For the sur-
ival experiments, the ﬁsh were i.p. injected with either 10 l of
Lc liposome (246 mg/kg liposomes containing 8.2 mg/kg poly(I:C)
nd 4.1 mg/kg LPS), 10 l of empty liposomes (246 mg/kg), 10 l
f a mixture of the free immunostimulants (8.2 mg/kg poly(I:C)
nd 4.1 mg/kg LPS) or 10 l of PBS (control). At 1, 7 or 30 days
ost-injection (dpi), the ﬁsh were challenged with P. aeruginosa
1.5 × LD50) and their survival was assessed for 5 days. All exper-
ments were done in triplicate and 12 individuals were used for
ach condition and experiment. A total number of 36 ﬁsh were
sed for each condition. Survival curves were analysed using the
aplan–Meier method and the statistic differences were evaluated
sing the log-rank test (GraphPad, USA). Relative percentage of
urvival (RPS) was calculated according to RPS (%) = [(1 − mortality
reated group)/mortality control] × 100.
.7. Cell cultures and Spring Viraemia of Carp Virus (SVCV)
reparation
The ﬁsh-cell line ZF4 [27] used in this work was purchased from
he American Type Culture Collection (ATCC number CRL-2050).
F4 cells were maintained at 28 ◦C in a 5% CO2. The 56/70 isolate of
VCV isolated from carp [28] was propagated in ZF4 cells at 22 ◦C.
upernatants from SVCV-infected cell monolayers were clariﬁed
y centrifugation at 4000 × g for 30 min  and stored in aliquots at
70 ◦C. The clariﬁed supernatants were used for in vivo infection
ssays.
.8. Spring Viraemia of Carp Virus (SVCV) challenge in zebraﬁsh
fter liposome administration
Zebraﬁsh were given NLc liposomes, empty liposomes or a
ixture of the free immunostimulants by either i.p. injection
r immersion, as described below. I.p. injection: the ﬁsh were
njected with either 10 l of NLc liposomes (246 mg/kg liposome
ontaining 8.2 mg/kg poly(I:C) and 4.1 mg/kg LPS), 10 l of empty
iposomes (246 mg/kg), 10 l of the mixture of free immunos-
imulants (8.2 mg/kg poly(I:C) and 4.1 mg/kg LPS) or 10 l of
BS (control). Immersion: the NLc liposomes (500 g/ml lipo-
omes containing 16.6 g/ml poly(I:C) and 8.3 g/ml LPS), empty (2014) 3955–3962 3957
liposomes (500 g/ml) and a mixture of the free immunostimulants
(16.6 g/ml poly(I:C) and 8.3 g/ml LPS) were each administrated
for 30 min, including a handling control. At 7 dpi, the zebraﬁsh
(n = 15/each condition) were infected by immersion with SVCV
(7.1 ± 2 × 107 pfu/ml) according to previously described infection
protocols [29,30]. Fish were assessed for survival, abdominal
distension, exophthalmia, impaired swimming and skin/ﬁn base
haemorrhages for 15 days. Survival curves were analysed using
the Kaplan–Meier method and the differences were evaluated
using the log-rank test (GraphPad). Relative percentage of survival
(RPS) was calculated according to RPS (%) = [(1 − mortality treated
group)/mortality control] × 100. At 5 dpi, two  surviving ﬁsh from
each group were randomly sampled for virus recovery [30].
3. Results
3.1. Biodistribution of NLc liposomes in zebraﬁsh after
administration by i.p. injection
The biodistribution of the NLc liposomes in adult zebraﬁsh
was studied following i.p. injection of the ﬁsh with ﬂuorescently
labelled liposomes (AF750-NLc liposomes). Whole-animal images
revealed a ﬂuorescence signal in the peritoneal cavity of all the
individuals up to 72 h with no detectable ﬂuorescence signal in
any other part of the ﬁsh (Fig. 1A). Quantiﬁcation of this sig-
nal conﬁrmed a sustained presence of the liposomal formulation.
A slight decrease was observed at 72 h: from 3.76 × 109 Radiant
Efﬁciency (RE) at 0 h to 2.16 × 109 RE at 72 h (Fig. 1B). Organ ex
vivo analysis was performed at 0, 24, 48 and 72 h post-injection,
and the corresponding signal intensities were quantiﬁed (Fig. 1C).
Signiﬁcant accumulation of the NLc liposomes was  observed in
the spleen from 0 to 72 h (from 1.92 × 106 RE/organ area at 0 h
to 1.05 × 106 RE/organ area at 72 h), and in the liver at 72 h
(5.71 × 105 RE/organ area). These values are consistent with those
from previous studies using radioactive labelling, which had shown
that large unilamellar liposomes injected into ﬁsh had localised
mainly in the spleen [13].
3.2. Cells targeted by NLc liposomes in rainbow trout
To identify the cells targeted by the NLc liposomes in vivo, we
worked with adult rainbow trout instead of zebraﬁsh, as the larger
size of the former enabled us to isolate mononuclear phagocytes
from the main immunologically related organs (spleen and head
kidney) for subsequent characterisation by ﬂow cytometry and by
confocal microscopy. In a typical experiment, ﬂuorescent NLc lipo-
somes were injected into trout (n = 4), and at 24 h post-injection
the spleen and the head kidney were dissected for primary cell cul-
ture. The NLc liposomes were tracked by ﬂow cytometry and by
confocal microscopy at 24, 48 and 72 h. Fluorescence signals were
signiﬁcantly detected by ﬂow cytometry (Fig. 2A) in spleen-derived
cells at 24, 48 and 72 h. NLc liposomes were also found in head
kidney-derived cells, although in far lower levels than in the spleen.
For example, at 72 h, the percentage of total positive cells in the
spleen was  30.3 ± 12.6%, compared to 2.9 ± 1.2% for the head kid-
ney. Interestingly, ﬂuorescent cells were detected even up to 6 days
post-injection, indicating that the NLc liposomes can persist for at
least 1 week (data not shown). For the confocal microscopy analysis,
the cell membranes and nuclei were stained with either CellMask
or Hoechst, respectively. The monocytes/macrophages were eas-
ily distinguishable by the kidney-shaped nuclei and the rugosity
of their plasma membranes (Fig. 2B and C) [31,32]. The presence
of NLc liposomes in macrophage-like cells from the spleen was
conﬁrmed at 24, 48 and 72 h (Fig. 2B). Fluorescent NLc liposomes
were also found in macrophage-like cells isolated from head kidney
3958 A. Ruyra et al. / Vaccine 32 (2014) 3955–3962
Fig. 1. Biodistribution time-course of the NLc liposomes after i.p. injection. (A) Representative IVIS Spectrum image of adult anaesthetised zebraﬁsh at 0, 24, 48 and 72 h
after  being i.p. injected with 10 l of AF750-NLc liposome formulation. Untreated ﬁsh were used as control for background subtraction. Image intensity is represented as
Radiant Efﬁciency. (B) AF750-NLc liposome ﬂuorescent signal quantiﬁcation from 0 to 72 h. Untreated ﬁsh were used as control (black dots). Image intensity is represented
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Lc liposomes. The ﬂuorescence intensity of the different organs was measured 
fﬁciency/organ area. Differences were analysed using One-way ANOVA followed b
Fig. 2C). The membrane-staining and the z-stack images enabled
isualisation of the exact location of the liposomes, and the images
emonstrated that the liposomes had been completely taken up
y the cells; no ﬂuorescent NLc liposomes attached to the plasma
embrane were detected (Fig. 2B and C(iii, iv)).
.3. NLc injected liposomes protect zebraﬁsh against P.
eruginosa lethal challenge
In previous work, we showed that NLc liposomes induced the
xpression of immunologically relevant genes in vitro [18]. Hav-
ng determined, in the present work, that these liposomes target
acrophage-like cells in vivo, we next studied the protective effect
f the system against P. aeruginosa infection. Before the immun-
sation experiments, the PAO1 infection model in adult zebraﬁsh
as fully characterised by determining the LD50 = 5.3 × 107 cfu
supplementary Fig. 1), and then recovering and subsequently iden-
ifying the PAO1 strain by 16S rRNA sequencing (data not shown).
he zebraﬁsh were immunised with the NLc liposomes, and then
hallenged with the PAO1 bacteria at 1 day, 1 week or 1 month post-
mmunisation. Their survival rates were assessed and the results
ere used to compare the different immunisation protocols (Fig. 3
nd supplementary Fig. 2 and Table 1). Neither the empty liposomes
or the mixture of free immunostimulants (poly(I:C) and LPS) pro-
ected the zebraﬁsh against PAO1 infection when injected 1 day
supplementary Fig. 2) or 1 week (Fig. 3A) before the challenge. In heart were removed at 0–72 h and imaged to reveal accumulation of the AF750-
the Caliper Living Image software. Data represent the mean ± SD (n = 4) Radiant
ey’s post-test. **p < 0.01; ***p < 0.001.
contrast, the ﬁsh that had received NLc liposomes exhibited signif-
icantly higher survival rates than the control group, regardless of
the date of administration (RPS of 33.2% at 1 day; 47.1% at 1 week;
and 36.3% at 1 month (Fig. 3, supplementary Fig. 2 and Table 1).
To determine the feasibility of using a storable version of the NLc
liposomes (supplementary Fig. 3), we  also evaluated the efﬁcacy
of lyophilised NLc liposomes against P. aeruginosa infection. Thus,
adult zebraﬁsh were treated with rehydrated lyophilised NLc lipo-
somes or with freshly prepared NLc liposomes, and then infected at
1 week post-injection (Fig. 3A). Interestingly, the lyophilised lipo-
somes were as effective as the freshly prepared ones (58.3% survival
vs. 50% survival, respectively; Fig. 3A). This result conﬁrmed that
lyophilised liposomes are amenable to use after long-term storage.
Supplementary material related to this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.vaccine.
2014.05.010.
3.4. NLc liposomes administered by i.p. injection protect zebraﬁsh
against Spring Viraemia of Carp Virus (SVCV) lethal challenge
The protective efﬁcacy of NLc liposomes against Spring Viraemia
of Carp Virus (SVCV) administered by i.p. injection was assessed in
adult zebraﬁsh. The ﬁsh were treated with NLc liposomes, empty
liposomes, the mixture of free immunostimulants (poly(I:C) and
LPS) or PBS. At 7 days post-injection, all the ﬁsh were subjected
to an immersion challenge with SVCV (Fig. 4). Similarly to the
A. Ruyra et al. / Vaccine 32 (2014) 3955–3962 3959
Fig. 2. Uptake of NLc liposomes by phagocytes from trout spleen and head kidney. (A) Quantiﬁcation of NLc liposomes uptake in spleen phagocytes and head kidney phagocytes
at  24, 48 and 72 h. FITC-NLc liposomes were i.p. injected into adult rainbow trout. Cells from untreated individuals were used as control (black dots). Data represent mean ± SD
(n  = 4) ﬂuorescence intensity (MFI) and differences were analysed using One-way ANOVA followed by Tukey’s post-test. *p < 0.05. Time-course of FITC-NLc liposome uptake
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iposomes (green) internalised in macrophage-like cells (ii). Cell membranes are sho
he  same cells.
acterial challenge neither the empty liposomes nor the mixture
f free immunostimulants offered any signiﬁcant protection
elative to the control ﬁsh, as measured at 15 days (RPS of empty
iposomes: 0%; free immunostimulants: 7.7%). Only the ﬁsh that
ad received NLc liposomes showed a signiﬁcantly higher survival
ate (RPS of 42.3% after 15 days) (Fig. 4 and supplementary Table
). This difference was evident throughout the entire experiment.
.5. Biodistribution of NLc liposomes in zebraﬁsh after
dministration by immersion
We  also evaluated the biodistribution of ﬂuorescently labelled
Lc liposomes (AF750-NLc liposomes) in zebraﬁsh following
dministration by immersion. The zebraﬁsh were treated by pla-
ing them into water tanks containing AF750-NLc liposomes. At
 h, ﬂuorescence was detected in the gills of all ﬁsh and by 12 h
ost-immersion, ﬂuorescence was still detected in the gills but was
lso detected in the abdominal region of most of the ﬁsh (83.3%)
Fig. 5A). To accurately gauge the organ distribution of the NLc
iposomes, ex vivo imaging was performed at 12 h post-immersion
Fig. 5B). Fluorescence was observed in the gills of all ﬁsh (100%),
nd in the intestine and the liver of some ﬁsh (83.3% and 50% of ﬁsh,
espectively). Thus, the results suggest that the NLc liposomes had
ttached to the gill surface, and that they had reached the liver and
he intestine. We cannot discard that NLc liposomes also reachedetry plot of FITC positive cells (i) and corresponding confocal images of FITC-NLc
 red and nuclei, in blue. Z-stack (iii) and whole-membrane (iv) digitalised image of
the intestine by the ﬁsh having swallowed water during immersion
[33].
3.6. NLc liposomes administered by immersion protect zebraﬁsh
against Spring Viraemia of Carp Virus (SVCV) lethal challenge
Having conﬁrmed that these liposomes can be administered by
immersion, we  then evaluated their efﬁcacy by the latter route
against SVCV immersion challenge. In this case, the empty lipo-
somes and the mixture of free immunostimulants gave a slight
increase in the survival at 13 days: RPS was  20.0% with empty
liposomes, 21.4% with free poly(I:C)/LPS (Fig. 6 and supplementary
Table 1). However, the only statistically signiﬁcant difference in the
entire survival curve was  observed in the NLc liposome-treated ﬁsh,
whose mortality was clearly delayed throughout the experiment
(RPS value of 33.3%) (Fig. 6 and supplementary Table 1).
4. Discussion
Our experiments on NLc liposomes administered to adult
zebraﬁsh by i.p. injection clearly indicated that the spleen was the
main organ in which the liposomes had accumulated. This ﬁnding is
consistent with the fact that the spleen is amongst the most impor-
tant organs for ﬁltering out foreign agents [34] and is the main
organ for antigen presentation in teleost ﬁsh [31]. Furthermore,
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Fig. 3. Survival of adult zebraﬁsh after i.p. injection of NLc liposomes and challenge
with P. aeruginosa (PAO1). (A) Fish were i.p. immunostimulated with NLc liposomes,
empty liposomes or free Poly (I:C)/LPS 7 days before being challenged with PAO1 at
the  LD50. NLc liposomes lyophilised for 4 months were also used. (B) Fish i.p injected
with NLc liposomes were also challenged with PAO1 one month after immunostim-
u
a
t
t
a
n
z
t
Fig. 4. Survival of adult zebraﬁsh after i.p. injection of NLc liposomes and immersion
challenge with Spring Viraemia of Carp Virus (SVCV). Fish were immunised with NLc
liposomes, empty liposomes or free Poly (I:C)/LPS by i.p. injection 7 days before being
challenged with SVCV by immersion. Untreated zebraﬁsh that had been infected
macrophages isolated from different tissues exhibited different
F
c
olation. Untreated zebraﬁsh that had been infected with PAO1 at the LD50 were used
s  mortality control. Differences were analysed using log rank test. *p < 0.05.
his result is in agreement with those of previous studies, in which
he uptake and retention of injected bacteria, vaccine antigens
nd liposomes were demonstrated in the spleen and the head kid-
ey [35,36]. However, we  did not detect any ﬂuorescent signal in
ebraﬁsh head kidney in vivo, although this was probably related to
he detection limit of the method. Nevertheless, our experiments on
ig. 5. Biodistribution of the NLc liposomes after immersion. (A) IVIS Spectrum images of
ontaining AF750-NLc liposomes. (B) Organs (including liver, intestine, spleen, heart, oper
f  AF750-NLc liposomes. Image intensity is represented as Radiant Efﬁciency. Non-immewith SVCV were used as mortality control. Differences were analysed using log rank
test. *p < 0.05.
NLc liposomes administered to adult rainbow trout by i.p. injection
demonstrated that the liposomes had accumulated in macrophage-
like cells extracted from the spleen and, to a lesser extent, from the
head kidney. These cells were identiﬁed as macrophages by their
size, phagosome-rich cytoplasm, characteristic kidney-shaped
nuclei and membrane rugosity [31,32].
The NLc uptake mechanisms in vivo probably would be different
depending on the tissue. In vitro trout macrophages internalised
the NLc liposomes mainly through caveolae-mediated endocy-
tosis and phagocytosis, while zebraﬁsh hepatocytes (ZFL cells)
internalised the NLc liposomes through caveolae-dependent and
clathrin-mediated endocytosis [18].
The difference in the amount of NLc liposomes found in
spleen and head-kidney macrophages could be explained by the
fact that the majority of the circulating monocyte/macrophages
would migrate to the spleen after mobilisation to the inﬂam-
matory site [37]. Another possible explanation might be thatphagocytic responses [38]. Macrophages help regulate the immune
response by producing cytokines and interferons and by presenting
antigens to lymphocytes [39]. Therefore, targeting the delivery
 adult anaesthetised zebraﬁsh (n = 6) at 0 and 12 h, after 30 min  immersion in water
culum and gills) and eggs were removed at 12 h and imaged to reveal accumulation
rsed ﬁsh were used as control for background subtraction.
A. Ruyra et al. / Vaccine 32
Fig. 6. Survival of adult zebraﬁsh after bath immersion with NLc liposomes and
immersion challenge with Spring Viraemia of Carp Virus (SVCV). Fish were immunos-
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[18] Ruyra A, Cano-Sarabia M,  Mackenzie SA, Maspoch D, Roher N. A novel liposome-
based nanocarrier loaded with an LPS-dsRNA cocktail for ﬁsh innate immune
system stimulation. PLoS ONE 2013;8:e76338.imulated by immersion in water containing NLc liposomes, empty liposomes or free
oly(I:C)/LPS 7 days before challenge. Untreated zebraﬁsh infected with SVCV were
sed as mortality control. Differences were analysed using log rank test. **p < 0.01.
ystems to these cells should be an excellent strategy to achieve
ptimal protection levels.
To test whether the NLc liposomes could protect ﬁsh against
acterial infection, we developed a new model using P. aeruginosa.
espite the current lack of models in adult zebraﬁsh, researchers
ave developed several models of bacterial (e.g. Streptococcus
niae or Mycobacterium marinum) or viral (e.g. VHSV) infection in
ebraﬁsh larvae over the past few years [40,24]. However, the
aturity of larval immune systems remains poorly understood.
e chose P. aeruginosa because it is an opportunistic pathogen in
sh [22] and in humans [23], is easy to handle, and is available in
ultiple virulence mutants. We  would like to highlight that ani-
al models of bacterial infection such as the one we developed
n this work might also prove valuable in therapeutic research for
umans, especially given the fact that immunosuppressed patients
e.g. cystic ﬁbrosis patients) are highly susceptible to P. aeruginosa
nfection.
The level of protection against infection by P. aeruginosa or by
VCV that we observed in the ﬁsh treated with NLc liposomes,
egardless of the administration route, suggests the potential util-
ty of these liposomes as a broad-spectrum tool for immunological
rotection of ﬁsh. Furthermore, the fact that the mixture of free
mmunostimulants did not offer protection in any of the infection
odels underscores the importance of encapsulating in liposomes
o ensure optimal activation of the immune system. Although i.p.
njection remains the most widely used route to administer vac-
ines, it suffers some disadvantages, such as stress and side-effects
t the injection site [41]. On the other hand, immersion and oral
dministration would be the preferable methods as they involve
ess handling costs and stress. However, the suitability in terms
f cost-effectiveness of each vaccination method will have to be
tudied for each particular disease/case. In regard to this, we also
valuated the use of immersion to deliver the liposomes, as this
ethod – in addition to being less time- and cost-dependent –
ffers another major advantage: the vaccine generates mucosal
mmunity at the site on the organism’s body at which it is most
ikely to encounter the pathogen [42]. Thus, liposomes not only pro-
ect encapsulated actives, they also enhance the immune response
y increasing mucosal adhesion [12,43].
In the present work, we found that the NLc liposomes had
ccumulated in the gills, where they most likely attached to the
pithelial cells and underlying phagocytes [33], and in the intes-
ine, another reported route of antigen entry in bath-immunised
sh [44,33]. The presence of NLc liposomes in the liver follow-
ng administration by immersion might be down to this organ’s
ole in detoxiﬁcation and lipid-processing [34]. This observation is
[
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consistent with previous studies in which encapsulated LPS was
found in the liver after oral administration, indicating that they
undergone intestinal absorption [45]. Although there have been
reports of failed attempts at using immersion to administer vac-
cines [46], this failure might be related to the vaccine composition
or because the use of the same route for vaccination and experi-
mental challenge is probably very important [9,11]. Accordingly,
we used an immersion infection model, observing a signiﬁcant
increase in the survival and a delay in the mortality. Thus, given
the promising results we  have obtained with NLc liposomes and
the fact these liposomes, once lyophilised, can be easily stored for
long periods of time without losing their efﬁcacy, we  are conﬁdent
that this approach will ultimately prove fruitful for use in diverse
therapeutic contexts.
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